Background: Peritoneal dialysis (PD) is associated with functional and structural
Introduction
Peritoneal dialysis (PD) is an effective treatment for patients with end-stage renal failure. During this treatment the peritoneal membrane functions as a dialyzing organ and is constantly exposed to PD-fl uid (PDF). It is well known that long-term PD induces loss of mesothelial cells, submesothelial thickening and neo-angiogenesis 1 . The nonphysiological environment in the peritoneum caused by chronic PDF installation, sustains a low grade of sterile infl ammation 1 . This low grade of infl ammatory state may on the long-term cause functional deterioration of the peritoneal membrane with increasing peritoneal permeability for small solutes and reduced ultrafi ltration (UF) capacity 2;3 . At the molecular level there is increasing evidence that cytokines, chemokines and growth factors play a key role in regulating and sustaining this pro-infl ammatory condition 4 . After long-term PD treatment, peritoneal mesothelial cells show a progressive loss of epithelial phenotype and acquire fi broblast-like characteristics, suggesting Epithelial to Mesenchymal Transition (EMT) 5 .
Heparin is a highly sulfated polysaccharide belonging to the family of glycosaminoglycans and is synthesized by mast cells. Although it is most known for its anticoagulant effect, heparin has a number of immunomodulatory and antiinfl ammatory activities, including the binding of cytokines, chemokines and growth factors 6 . Ear lier reports demonstrate that heparin can inhibit leukocyte rolling along the vessel wall, a process which is known to involve selectins 7;8 . The function of selectins in this process depends on recognition of specifi c glycoprotein ligands.
However, a variety of carbohydrate structures, including heparin, may bind these lectin-like molecules and interfere with ligand binding 9 . Besides unfractionated heparin (UFH), low molecular weight heparin (LMWH) is one of the most common used types of heparin in clinical settings. LMWH fractions are prepared from standard unfractionated heparin and are similar to UFH in many aspects. The main advantages of this class of anti-thrombotic agents as compared with UFH are an improved bioavailability, a prolonged half-life (which may permit one single daily subcutaneous injection) and a more improved effi cacy 10;11 .
In clinical PD settings heparin is used to prevent fi brin formation during peritonitis and at times of catheter obstructions. The results on the effects of intraperitoneal heparin administration on peritoneal transport and infl ammation have been contradictory [12] [13] [14] [15] [16] .
Therefore, we have studied long-term addition of UFH as well as LMWH to the PDF on function, defence and tissue remodelling of the peritoneal membrane to see whether heparin can improve peritoneal transport and whether it can also prevent morphological changes of peritoneal tissues. In the present study either UFH or LMWH was added to the PDF in a chronic peritoneal exposure model in the rat for fi ve weeks 17;18 .
Material and Methods

Animals
Male Wistar rats (Harlan CPB, Horst, The Netherlands) weighing 250-275 gr. at the beginning of the experiment were used throughout the study. They were allowed one week of acclimatization before the start of the experiment. Animals were housed under conventional laboratory conditions and were given food and water ad libitum.
The Animal Experimental Committee of the Vrije Universiteit of Amsterdam approved the experimental design.
Experimental design
Fluids were instilled via a peritoneal catheter connected to an implanted subcutaneous mini access port as previously described 19 . Rats that were not surgically treated and received no fl uid instillation, served as control group (n=8). The remainder of the animals (n=34) received 2 ml of saline with 1 IU/ml heparin to allow wound healing during the fi rst week after operation. Thereafter, during a fi ve week period [20] [21] [22] [23] , rats
were daily instilled with 10 ml of standard PDF (Dianeal ® PD4, 3.86% glucose, pH 5.2, Baxter R&D, Utrecht, The Netherlands) (PDF-control; n=14), PDF with addition of unfractionated heparin (PDF-UFH; n=10) or PDF with addition of low molecular weight heparin (Fraxiparine ®) (PDF-LMWH; n=10). The concentrations used for UFH as well as LMWH (1 mg/rat/day, equivalent to 175 IU UFH /rat/day or 100 IU LMWH /rat/day) are consistent with the concentrations used in clinical settings and proportional to the dose used in deep venous thrombosis prophylaxis in humans 24 . To check whether the animals were not over-heparinised due to daily heparin administration, blood samples were taken after 4 weeks of treatment three hours after PDF + heparin instillation, to measure APTT clotting times and anti factor Xa levels. At the end of the experiment a functional 90 minute Peritoneal Equilibrium Test (PET) was performed (see below) under a mixture of Hypnorm (0.05 ml/100 g) / Dormicum (0.08 ml/100 g) anaesthesia. After sacrifi cing the animals, tissues and peritoneal leukocytes were taken to analyse functional, morphological and cellular parameters.
Analysis of peritoneal cells and effl uents
After fi ve weeks of treatment a PET test was performed by injecting 30 ml of standard PDF into the peritoneal cavity via a direct i.p. catheter (Venfl on Pro, BD Medical, New
Jersey, USA). After 90 minutes the PDF was drained and the ultrafi ltration capacity was calculated. Cells were isolated by centrifugation and cell number and viability was determined by Trypan Blue exclusion. Cytocentrifuge preparations were stained by May Grünwald Giemsa, and cells were differentiated. After the PET test, the animals were sacrifi ced and a cardiac puncture was performed. Glucose, sodium, creatinine and urea concentrations were analysed in serum samples and in the cell free effl uents at t=90 minutes of the PET test. At t=0 and t=45, sodium concentrations in the effl uents were analysed to measure sodium sieving. The amount of hyaluronic acid (HA) in the supernatant of the peritoneal effl uent was determined in an ELISAbased assay according to Fosang et al 25 . Liver imprints: Imprints of the mesothelial monolayer of the liver were taken with 3% gelatin coated slides according to the method described before 26 and stained by May Grünwald Giemsa. Mesothelial cell density per 0.1 mm 2 area was counted using a 'scored eyepiece' and the mean of 15 areas was calculated for each slide and expressed as cells/mm 2 . Liver imprints were also stained for Vimentin (Serotec, Oxford, UK) and Cytokeratin (DakoCytomation, Glostrup, Denmark) to determine spindle-like shaped cells that underwent epithelial to mesenchymal transition (EMT).
Morphological analysis
Statistical analysis
All data are presented as median and inter quartiles. The Kolmogorov-Smirnov test for normality showed that the groups were not normally distributed, therefore differences between groups have been analysed using the nonparametric MannWhitney U-test. We made three comparisons, namely: Control vs. PDF-control, PDF-control vs. PDF-UFH and PDF-control vs. PDF-LMWH. According to a Bonferroni correction, probability values of p<0.03 were considered signifi cant. Correlation analysis was performed using the non-parametric Spearman's Rho test. Survival analysis was performed by Kaplan Meier.
Results
During the experiment, the well-being of all animals was monitored daily, but no apparent abnormalities were observed. Throughout the experiment there was a dropout of a number of animals due to abdominal fat or omental tissue wrapping around the tip of the catheter, which was consistent with earlier experience 17;27 . Although it was expected that heparin would impair fi brin formation and may prevent adhesion and omental wrapping, Kaplan Meier survival analysis showed no differences in drop out rate (neither in time, nor in number) between the three treated groups. The development of peritonitis during the experiment is very unlikely since there was no loss of bodyweight, the animals did not show any other clinical signs and there were no abnormalities in neutrophil counts in peritoneal dialysates or in peritoneal tissues.
After 5 weeks of fl uid instillation 8, 5, and 5 rats in the PDF-control, PDF-UFH and PDF-LMWH group, respectively, had remained for analysis. All 8 control rats were used for the PET and morphological analysis. APTT and anti-Xa measurements
showed that daily i.p. treatment with clinical concentrations of 1 mg/day of heparin did not signifi cantly infl uence clotting times 3 hours after heparin injection. Plasma anti-Xa levels were higher in the PDF-LMWH group compared to the control groups (p=0.048). Although this difference was just not signifi cant, it indicates that heparin was administered in an adequate dose without over-heparinization of the animals.
Transport parameters and cellular composition of peritoneal cells Table 1 shows the transport parameters measured for all 4 groups in the PET effl uents at t=90 minutes. The PET in the control animals resulted in a net UF capacity of 8.6 ml per 90 minutes.
PDF exposure reduced peritoneal performance signifi cantly to a net UF volume of 6.5 ml. Addition of UFH or LMWH reduced the UF capacity even slightly further from PDF-control group. Besides the reduced net UF capacity, PDF induced signifi cantly enhanced glucose absorption (p< 0.03) and an increased urea transport (p<0.02).
Sodium measurements at t=0, t=45 and t=90 minutes of the PET test, showed a reduction in the sodium dip upon PDF treatment (Control vs. PDF-control at t=90:
p<0.03). The addition of UFH or LMWH did not restore PDF-induced changes in peritoneal transport (Table 1 ).
In table 2 the total cell numbers and differentiation of the peritoneal cells recovered from the PET dialysate are shown. Signifi cantly more cells were found in the peritoneal effl uents of the three PDF treated groups compared to the control animals (p<0.02).
No difference in cell numbers was seen between PDF-control and both heparin groups. Cell differentiation revealed an exchange of mast cells and eosinophils for neutrophils after PD treatment. UFH as well as LMWH treatment seemed to partly abolish the PD evoked infl ammation by reducing neutrophil recruitment.
Furthermore, addition of UFH or LMWH resulted in a slightly reduced hyaluronan synthesis compared to the PDF-control group (Table 2) .
Morphological changes
Mesentery and Omentum: All groups exposed to PDF showed a signifi cant increase (Figure 2A ).
No differences were found between the PDF treated groups. Sections of the peritoneum were also stained for CD31 and ED2. Similar to the morphological changes found in the mesentery and the omentum, signifi cant more macrophages and blood vessels were seen in PDF treated animals compared to the control group, without any differences between the three PDF treated groups ( Figure 2B-2G ). Correlation analysis showed again a signifi cant positive relation for increased macrophage accumulation and blood vessel density (r =0.76, p<0.01). Positive correlations were also found for matrix thickness and CD31 (r =0.78, p< 0.01) and for matrix thickness and ED2 (r =0.76, p< 0.01). Liver Imprints: Mesothelial cell density was measured as a marker for mesothelial cell regeneration. The number of mesothelial cells on the liver showed a signifi cant 2 fold increase up to 2044.8 +/-548.4 cells /mm 2 in the PDF-control group compared to the untreated animals (1167.6 +/-272.6 cells/mm 2 p< 0.01) ( Figure 3A and B). Neither of the 2 heparins was able to infl uence mesothelial cell regeneration.
Spindle-like shaped cells were found between mesothelial cells in PDF treated animals ( Figure 3B ). An average of 7-10% of the cells found on the liver imprints of PDF treated animals showed this phenotype, whereas these cells were not found in control animals (p<0.01). No differences in spindle shaped cell numbers were found between the three PDF exposed groups. A vimentin positive and cytokeratin negative staining ( Figure 3C and 3D) identifi ed those cells as fi broblasts-like cells, indicating either that the imprint is picking up submesothelial fi broblasts due to partial injury and denudation of mesothelial cells, or possibly mesothelial cells undergoing EMT ( Figure 3D ). 
Discussion
In our study either UFH or LMWH was added to conventional PDF, based on the characteristics of heparins to reduce new vessel formation, block leukocyte rolling and adhesion, and the capability to bind cytokines and growth factors 6 . We show signifi cant worsening in peritoneal performance after fi ve weeks of PDF exposure evidenced by high transport characteristics, infl ammation and peritoneal tissue remodelling. Moreover mesothelial imprints revealed fi broblast-like cells upon PDF exposure. However, none of these PDF induced events could be diminished or prevented by the addition of UFH or LMWH to the PDF.
We decided to add heparins to the PDF in order to obtain maximal local availability and minimize systemic effects of the heparin intervention. Non signifi cant changes in APTT clotting times and anti-factor-Xa levels indicated that the animals were not over-heparinized during the experiment, whereas increased plasma Xa levels after LMWH administration, showed that adequate working doses were administered.
The concentrations used for UFH as well as LMWH are clinically relevant doses and were similar or even higher compared to the literature 15;24;28-30 . Higher concentrations of heparin might have led to bleeding complications or heparin induced thrombocytopenia 31 . The normal clotting times in animals which received daily heparin, might in part be due to the fact that i.p. heparin barely reached the circulation or that it already left the circulation within three hours after administration.
In line with our results are the unaffected APTT and anti factor Xa measurements of PD patients which received an i.p. injection with LMWH 14;32;33 , whereas increased plasma factor Xa levels were seen after subcutaneous injection 33 . These data indicate that intraperitoneal administration of heparin only have minor partial systemic effects 32;33 .
Although our intention to avoid systemic effects of heparin treatment was successful, none of the PDF induced peritoneal changes could be (partly) prevented by the local heparin treatment. Since we were especially interested in the long-term effects of heparin treatment and to avoid direct effects of heparin, we treated the animals daily during fi ve weeks and performed the PET tests without heparin one day after the last heparin gift. Identical methodological approach has been successfully applied in the past with i.p. aminoguanidine treatment 34 . This is an important difference with some other studies, and might explain why others reported benefi cial effects of glycosaminoglycans such as heparin or hyaluronan that was present in the PDF during the PET procedure 15;35 , which is explained by a reduction of the peritoneal fl uid reabsorption rate due to the formation of a fi lter-cake of the glycosaminoglycans chains at the tissue/cavity interface.
The fact that chronic treatment with either of the heparins did not prevent peritoneal membrane remodelling (new vessel formation, fi brosis, macrophage infl ux and mesothelial EMT) might largely explain why the peritoneal transport parameters in the heparin treated groups were not different from the PDF-control group, since molecular transport is highly dependent on vascular surface area and submesothelial matrix thickness and composition 36 . Positive effects of heparin on peritoneal transport are reported in studies of Pawlaczyc et al 13 and Sjoland et al 14 . However, the fi rst study only showed marginal, non signifi cant, differences of heparin after 30 days of treatment and to our best knowledge the second study has not been confi rmed by others.
The absence of any effect of chronic heparin treatment on peritoneal infl ammatory markers like cell infl ux, might be explained by the fact that intraperitoneal cell recruitment occurs at the level of post-capillary venules 22 and via the omentum 23 .
We show that micro vascular density in the peritoneal tissues was unchanged by heparin treatment. Moreover, the absence of heparin in the circulation during the PET procedure allows normal selectin-ligand interaction, which is the fi rst step in leukocyte-endothelial interaction. There have been reports of anti-infl ammatory properties of heparinoids in other peritoneal infl ammatory models. However, in all those studies the heparinoids were given intravenously and present in systemic circulation thereby inhibiting L-and/or P-selectin dependent peritoneal cell infl ux 8;37-40 .
In line with our results, heparin showed no effects on PDF induced neutrophil numbers 15 , nor did it show effect on infl ammatory cells, fi brosis and angiogenesis in an animal model for abdominal wound healing 30 .
Concerning the role of heparins on angiogenesis, opposite results have been described 30;41 . In general, tumor angiogenesis seems to be highly dependent on fi brin formation and tissue factor pathway, processes that are highly modulated by heparin 42 . However, not all forms of new vessel formation are fi brin and/or tissue factor dependent. An impressive number of factors and mediators might be involved, highly dependent on the model system used 43 . The fact that chronic heparin treatment did not prevent neo-angiogenesis suggests that intraperitoneal fi brin formation is not involved in our experimental PD model.
Another intriguing fi nding was the appearance of vimentine-positive, cytokeratinnegative, spindle like shaped cells within the mesothelial monolayer, which suggests EMT of the mesothelial cells. An alternative explanation would be that the spindle like shaped cells might be submesothelial fi broblasts which are picked up by the either of the heparins did not modify this process and could neither affect mesothelial regeneration, evidenced by increased mesothelial cell density on the liver imprints.
In conclusion, we have confi rmed and extended that PD induces signifi cant worsening of the peritoneal tissues within 5 weeks. Moreover, we have shown an induction of spindle like shaped cells in the mesothelium, indicating either mesothelial damage or EMT. Secondly, we conclude that based on our fi ndings intraperitoneal addition of UFH or LMWH to PDF does not improve peritoneal transport, nor does it infl uence the remodelling of peritoneal tissues during PD treatment. Therefore, long term peritoneal administration of heparin during chronic PD treatment is not supported by our data.
